Results 271 to 280 of about 72,335 (302)
Some of the next articles are maybe not open access.
Endocrine Practice, 1998
To review the amiodarone-associated alterations in thyroid hormone metabolism and thyroid function and compare them with the effects of inorganic iodide. To clarify the pathophysiologic features and treatment of amiodarone-associated hypothyroidism and thyrotoxicosis.Amiodarone, an iodinated benzofuran, is an important antianginal and antiarrhythmic ...
S B, Seminara, G H, Daniels
openaire +2 more sources
To review the amiodarone-associated alterations in thyroid hormone metabolism and thyroid function and compare them with the effects of inorganic iodide. To clarify the pathophysiologic features and treatment of amiodarone-associated hypothyroidism and thyrotoxicosis.Amiodarone, an iodinated benzofuran, is an important antianginal and antiarrhythmic ...
S B, Seminara, G H, Daniels
openaire +2 more sources
Annals of Internal Medicine, 1983
Excerpt To the editor: Marchlinski and associates (1) have recently reported pneumonitis in four patients after treatment with amiodarone and, on the basis of their ultrastructural findings, have q...
J, Antolin +3 more
openaire +2 more sources
Excerpt To the editor: Marchlinski and associates (1) have recently reported pneumonitis in four patients after treatment with amiodarone and, on the basis of their ultrastructural findings, have q...
J, Antolin +3 more
openaire +2 more sources
The American Journal of Cardiology, 1985
Abstract Amiodarone is a potent new antiarrhythmic agent that is structurally similar to thyroxine. It has a long half-life (about 1 month), which makes management of side effects difficult. It crosses the placenta, so its use in women of child-bearing age is a problem in terms of possible fetal damage, even if it is stopped before conception ...
I M, Penn +5 more
openaire +2 more sources
Abstract Amiodarone is a potent new antiarrhythmic agent that is structurally similar to thyroxine. It has a long half-life (about 1 month), which makes management of side effects difficult. It crosses the placenta, so its use in women of child-bearing age is a problem in terms of possible fetal damage, even if it is stopped before conception ...
I M, Penn +5 more
openaire +2 more sources
Acta Medica Scandinavica, 1986
ABSTRACT.Amiodarone has proved very effective in the treatment of otherwise resistant cardiac tachyarrhythmias. The use of amiodarone has, however, been limited due to its serious side‐effects. A patient with cholestatic hepatitis due to amiodarone treatment is presented below and a review of the hepatotoxicity of amiodarone is given.
openaire +2 more sources
ABSTRACT.Amiodarone has proved very effective in the treatment of otherwise resistant cardiac tachyarrhythmias. The use of amiodarone has, however, been limited due to its serious side‐effects. A patient with cholestatic hepatitis due to amiodarone treatment is presented below and a review of the hepatotoxicity of amiodarone is given.
openaire +2 more sources
Ophthalmologica, 1980
6 cardiac patients were found to present various degrees of corneal involvement following systemic treatment with amiodarone. The clinical pattern of the keratopathy, its benign course and the pathophysiology are discussed. Lacrimal insufficiency or incomplete blinking seem to contribute to the severity of the keratopathy.
V, Feiler-Ofry +3 more
openaire +2 more sources
6 cardiac patients were found to present various degrees of corneal involvement following systemic treatment with amiodarone. The clinical pattern of the keratopathy, its benign course and the pathophysiology are discussed. Lacrimal insufficiency or incomplete blinking seem to contribute to the severity of the keratopathy.
V, Feiler-Ofry +3 more
openaire +2 more sources
Annals of Internal Medicine, 1985
Excerpt To the editor: Mazonson and associates (1) report that myxedema is not an uncommon occurrence during amiodarone therapy.
L E, Alves, E P, Rose, T B, Cahill
openaire +2 more sources
Excerpt To the editor: Mazonson and associates (1) report that myxedema is not an uncommon occurrence during amiodarone therapy.
L E, Alves, E P, Rose, T B, Cahill
openaire +2 more sources
Neurology, 1983
Amiodarone, a drug used to treat refractory cardiac arrhythmias, produced a peripheral neuropathy in 5 of 50 cases (10%). Although the neuropathy may be severe, it tends to improve with lowering of the dosage or discontinuation of the medication.
A, Martinez-Arizala +4 more
openaire +2 more sources
Amiodarone, a drug used to treat refractory cardiac arrhythmias, produced a peripheral neuropathy in 5 of 50 cases (10%). Although the neuropathy may be severe, it tends to improve with lowering of the dosage or discontinuation of the medication.
A, Martinez-Arizala +4 more
openaire +2 more sources
Current Vascular Pharmacology, 2008
Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding whether to initiate or continue treatment with this medication. While mostly associated with long-term oral administration of the drug, toxicity has also been reported early during intravenous administration and months after discontinuation of therapy.
Mohamed, Babatin +2 more
openaire +2 more sources
Potential hepatotoxicity related to amiodarone therapy is often a concern when deciding whether to initiate or continue treatment with this medication. While mostly associated with long-term oral administration of the drug, toxicity has also been reported early during intravenous administration and months after discontinuation of therapy.
Mohamed, Babatin +2 more
openaire +2 more sources
Best Practice & Research Clinical Endocrinology & Metabolism, 2009
Assessment of TSH and TPO-Ab before starting amiodarone (AM) treatment is recommended. The usefulness of periodic TSH measurement every 6 months during AM treatment is limited by the often sudden explosive onset of AIT, and the spontaneous return of a suppressed TSH to normal values in half of the cases.
Eskes, Silvia A., Wiersinga, Wilmar M.
openaire +3 more sources
Assessment of TSH and TPO-Ab before starting amiodarone (AM) treatment is recommended. The usefulness of periodic TSH measurement every 6 months during AM treatment is limited by the often sudden explosive onset of AIT, and the spontaneous return of a suppressed TSH to normal values in half of the cases.
Eskes, Silvia A., Wiersinga, Wilmar M.
openaire +3 more sources